Vikas Kumar Dawra

Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia

David P. Walling, Anindita Banerjee, Vikas Kumar Dawra et al. · Journal of Clinical Psychopharmacology · 2019 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed‐Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin

Vaishali Sahasrabudhe, Daryl J. Fediuk, Kyle Matschke et al. · Clinical Pharmacology in Drug Development · 2018 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects

Vikas Kumar Dawra, David L. Cutler, Susan Zhou et al. · Clinical Pharmacology in Drug Development · 2018 · 29 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Effect of Rifampin on the Pharmacokinetics of Ertugliflozin in Healthy Subjects

Vikas Kumar Dawra, Vaishali Sahasrabudhe, Yali Liang et al. · Clinical Therapeutics · 2018 · 22 citations

Medicine, Pharmacokinetics, Pharmacology +6

A PK/PD study comparing twice-daily to 
once-daily dosing regimens of ertugliflozin in healthy subjects

Vikas Kumar Dawra, Yali Liang, Haihong Shi et al. · International Journal of Clinical Pharmacology and Therapeutics · 2019 · 17 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13